• Je něco špatně v tomto záznamu ?

Quantum dots implementation as a label for analysis of early stages of EGF receptor endocytosis: a comparative study on cultured cells

AV. Salova, TN. Belyaeva, EA. Leontieva, MV. Zlobina, MV. Kharchenko, ES. Kornilova,

. 2016 ; 7 (5) : 6029-47.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014176

EGF complexed to fluorescent photostable quantum dots by biotin-streptavidin system (bEGF-savQD) is attractive for both the basic research and therapeutic application such as targeted drug delivery in EGF-receptor (EGFR) expressing cancers. However, compared to native EGF, the large size of QD and its quasi-multivalency can have unpredictable effects on EGFR endocytosis changing the internalization portal and/or endosomal processing tightly bound to EGF signaling. We have found that bEGF-savQDs enter HeLa cells via the temperature-dependent clathrin-mediated EGF-receptor-specific pathway characteristic for native EGF. We also found that EGF-to-QD concentration ratios used for the complex preparation and the level of EGF receptor expression affect the number and integral densities of the formed endosomes. So, at EGF-to-QD ratio from 4:1 to 12:1 (at nanomolar bEGF concentrations) on average 100 bright endosomes per HeLa cell were formed 15 min after the complex addition, while 1:1 ratio resulted in formation of very few dim endosomes. However, in A431 cells overexpressing EGFR 1:1 ratio was effective. Using dynamin inhibition and Na-acidic washout we showed that bEGF-savQDs bind surface receptors and enter clathrin-coated pits slower than the same ligands without QD. Yet, the bEGF-savQD demonstrated similar to native EGF and bEGF-savCy3 co-localization dynamics with tethering protein EEA1 and HRS, the key component of sorting ESCRT0 complex. In conclusion, our comparative study reveals that in respect to entrapment into coated pits, endosomal recruitment, endosome fusions, and the initial steps of endosomal maturation, bEGF-savQD behaves like native EGF and QD implementation does not affect these important events.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014176
003      
CZ-PrNML
005      
20170427102014.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.18632/oncotarget.6720 $2 doi
035    __
$a (PubMed)26716513
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Salova, Anna V $u Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia.
245    10
$a Quantum dots implementation as a label for analysis of early stages of EGF receptor endocytosis: a comparative study on cultured cells / $c AV. Salova, TN. Belyaeva, EA. Leontieva, MV. Zlobina, MV. Kharchenko, ES. Kornilova,
520    9_
$a EGF complexed to fluorescent photostable quantum dots by biotin-streptavidin system (bEGF-savQD) is attractive for both the basic research and therapeutic application such as targeted drug delivery in EGF-receptor (EGFR) expressing cancers. However, compared to native EGF, the large size of QD and its quasi-multivalency can have unpredictable effects on EGFR endocytosis changing the internalization portal and/or endosomal processing tightly bound to EGF signaling. We have found that bEGF-savQDs enter HeLa cells via the temperature-dependent clathrin-mediated EGF-receptor-specific pathway characteristic for native EGF. We also found that EGF-to-QD concentration ratios used for the complex preparation and the level of EGF receptor expression affect the number and integral densities of the formed endosomes. So, at EGF-to-QD ratio from 4:1 to 12:1 (at nanomolar bEGF concentrations) on average 100 bright endosomes per HeLa cell were formed 15 min after the complex addition, while 1:1 ratio resulted in formation of very few dim endosomes. However, in A431 cells overexpressing EGFR 1:1 ratio was effective. Using dynamin inhibition and Na-acidic washout we showed that bEGF-savQDs bind surface receptors and enter clathrin-coated pits slower than the same ligands without QD. Yet, the bEGF-savQD demonstrated similar to native EGF and bEGF-savCy3 co-localization dynamics with tethering protein EEA1 and HRS, the key component of sorting ESCRT0 complex. In conclusion, our comparative study reveals that in respect to entrapment into coated pits, endosomal recruitment, endosome fusions, and the initial steps of endosomal maturation, bEGF-savQD behaves like native EGF and QD implementation does not affect these important events.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kultivované buňky $7 D002478
650    _2
$a endocytóza $x fyziologie $7 D004705
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    12
$a kvantové tečky $7 D045663
650    _2
$a erbB receptory $x analýza $x metabolismus $7 D066246
650    _2
$a signální transdukce $7 D015398
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Belyaeva, Tatiana N $u Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia.
700    1_
$a Leontieva, Ekaterina A $u Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia.
700    1_
$a Zlobina, Maria V $u Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia. Central European Institute of Technology, Brno, Czech Republic.
700    1_
$a Kharchenko, Marianna V $u Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia.
700    1_
$a Kornilova, Elena S $u Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia. Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia. St. Petersburg State University, St. Petersburg, Russia.
773    0_
$w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 7, č. 5 (2016), s. 6029-47
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26716513 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427102334 $b ABA008
999    __
$a ok $b bmc $g 1200641 $s 974954
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 7 $c 5 $d 6029-47 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace